Search Results - "SHOUPE, D"

Hormone replacement therapy: consensus and controversies by Shoupe, D

“…While the use of menopausal hormone therapy [MHT] when initiated in women younger than 60 years is generally considered to have a good safety profile and to be…”
Get more information

Individualizing hormone-therapy according to cardiovascular risk by Shoupe, D

“…There is growing consensus that the benefit to risk profile for hormone therapy is high for healthy, low-risk women initiating therapy within 10 years of…”
Get more information

Estrogen in the prevention of atherosclerosis: A Randomized, double-blind, placebo-controlled trial by HODIS, Howard N, MACK, Wendy J, LOBO, Roger A, SHOUPE, Donna, SEVANIAN, Alex, MAHRER, Peter R, SELZER, Robert H, LIU, Chao-Ran, LIU, Ci-Hua, AZEN, Stanley P

“…Although observational studies suggest that estrogen replacement therapy (ERT) reduces cardiovascular morbidity and mortality in postmenopausal women, use of…”
Get full text

Contributing factors for menopausal symptoms after surgical staging for endometrial cancer by Cahoon, S.S, Gualtieri, M.R, Hasegawa, K, Shoupe, D, Muderspach, L.I, Matsuo, K

Get full text

The detection and clinical utilization of anti-Mullerian hormone (AMH) in postmenopausal women using the new highly sensitive ELISA by Buckbinder, J, Mucowski, S, Burks, H, Stanczyk, F.Z, Hodis, H.N, Mack, W, Bendikson, K.A, Shoupe, D

Get full text

Estrogen for Alzheimer's disease in women : Randomized, double-blind, placebo-controlled trial by HENDERSON, V. W, PAGANINI-HILL, A, MILLER, B. L, ELBLE, R. J, REYES, P. F, SHOUPE, D, MCCLEARY, C. A, KLEIN, R. A, HAKE, A. M, FARLOW, M. R

“…AD, the most prevalent cause of dementia, affects twice as many women as men. Therapeutic options are limited, but results of prior studies support the…”
Get full text

Early surgical menopause and increased risk of fatty liver disease in endometrial cancer by Matsuo, K, Jung, C.E, Cahoon, S.S, Paulson, R.J, Shoupe, D, Muderspach, L.I, Wakatsuki, A, Roman, L.D

Get full text

The Effect of Soy Isoflavones on Menopausal Vasomotor Flushing by Mucowski, S.J, Shoupe, D, Dang, H, Henderson, V, Kono, N, Hodis, H.N, Mack, W.J

Get full text

Surgical Menopause and the Increased Risk of Non-Alcoholic Fatty Liver Disease in Patients with Endometrial Hyperplasia and Cancer by Gualtieri, M., MD, Cahoon, S.S., MD, Paulson, R.J., MD, Shoupe, D., MD, MBA, Muderspach, L.I., MD, Roman, L.D, Matsuo, K., MD, PhD

Get full text

The effect of prior hysterectomy and/or oophorectomy on changes in bone mineral density (BMD) and carotid intima-media thickness (CIMT) in postmenopausal women by Mucowski, S.J, Mack, W.J, Kono, N, Paulson, R, Shoupe, D, Hodis, H.N

Get full text

A double-blind, placebo controlled trial on the effects of a licorice extract on menopausal symptoms by Baker, M.B, Ciccone, M, Wilson, M, Stanczyk, F, Shoupe, D

Get full text

The Effect of Isoflavone Soy Protein (ISP) Supplementation on Endometrial Thickness, Hyperplasia and Endometrial Cancer Risk in Postmenopausal Women: A Randomized Controlled Trial by Quaas, A.M, Kono, N, Mack, W.J, Hodis, H, Paulson, R.J, Shoupe, D

Get full text

Androgens and bone: Clinical implications for menopausal women by Shoupe, Donna

“…Osteoporosis is a common problem, affecting >28 million Americans, ≥75% of whom are postmenopausal women. In 1995 the cost of caring for patients with…”
Get full text

Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome by Mezrow, G, Shoupe, D, Spicer, D, Lobo, R, Leung, B, Pike, M

“…To test the effectiveness and safety of long-term depot leuprolide acetate (GnRH-a) plus estrogen and progestin add-back therapy in the treatment of moderate…”
Get more information

Risk of ovarian torsion in patients with ovarian hyperstimulation syndrome by Mandelbaum, R., Matsuo, K., Awadalla, M., Shoupe, D., Chung, K.

Get full text

Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk by Spicer, D V, Ursin, G, Parisky, Y R, Pearce, J G, Shoupe, D, Pike, A, Pike, M C

“…It has been known for some time that oral contraceptives substantially reduce the risk of endometrial and ovarian cancer, but they do not reduce the risk of…”
Get more information

HRT dosing regimens: continuous versus cyclic-pros and cons by Shoupe, D

“…The introduction of new products, lower dosages, and better continuous and cyclic regimens allows for individualized treatment aimed at minimizing risk and…”
Get more information

Utilization and outcomes of ovarian conservation at the time of hysterectomy for cervical cancer by Mandelbaum, R., Adams, C., Shoupe, D., Chung, K., Roman, L.D., Matsuo, K.

Get full text

Patterns of utilization and outcomes of ovarian conservation for young women with minimum-risk endometrial cancer by Mandelbaum, R.S., Chen, L., Shoupe, D., Roman, L.D., Wright, J.D., Matsuo, K.

Get full text

Effects of desogestrel on carbohydrate metabolism by Shoupe, D

“…Associated with progesterone and the synthetic progestins used in oral contraceptives is a dose-dependent impairment of carbohydrate metabolism. It is well…”
Get more information